CervoMed | 424B3: Prospectus
CervoMed | 424B3: Prospectus
CervoMed | EFFECT: Others
Diffusion Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Diffusion Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Diffusion Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Diffusion Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Diffusion Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Diffusion Pharmaceuticals | EFFECT: Others
Diffusion Pharmaceuticals | 424B3: Prospectus
Diffusion Pharmaceuticals | S-4/A: Registration of securities issued in business combination transactions (Amendment)
Diffusion Pharmaceuticals | S-4/A: Registration of securities issued in business combination transactions (Amendment)
Diffusion Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Diffusion Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Diffusion Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Diffusion Pharmaceuticals | S-4: Registration of securities issued in business combination transactions
Diffusion Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Diffusion Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Diffusion Pharmaceuticals | 424B5: Prospectus
Diffusion Pharmaceuticals | 424B5: Prospectus
No Data